NATURE’S SUNSHINE PRODUCTS, INC. Operating Lease Cost
NATURE’S SUNSHINE PRODUCTS, INC. (NATR) reported Operating Lease Cost of $5.30 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-10.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:OperatingLeaseCost · last filed 2026-03-10
- NATURE’S SUNSHINE PRODUCTS, INC. operating lease, cost for the quarter ending 2019-12-31 was $1.60M.
- NATURE’S SUNSHINE PRODUCTS, INC. operating lease, cost for the quarter ending 2019-09-30 was $1.70M.
- NATURE’S SUNSHINE PRODUCTS, INC. operating lease, cost for the quarter ending 2019-06-30 was $1.70M.
- NATURE’S SUNSHINE PRODUCTS, INC. operating lease, cost for the quarter ending 2019-03-31 was $1.60M.
- NATURE’S SUNSHINE PRODUCTS, INC. operating lease, cost for fiscal 2025 was $5.30M, a 1.85% decline from fiscal 2024.
- NATURE’S SUNSHINE PRODUCTS, INC. operating lease, cost for fiscal 2024 was $5.40M, a 3.85% increase from fiscal 2023.
- NATURE’S SUNSHINE PRODUCTS, INC. operating lease, cost for fiscal 2023 was $5.20M, a 1.89% decline from fiscal 2022.
- NATURE’S SUNSHINE PRODUCTS, INC. operating lease, cost for fiscal 2022 was $5.30M, a 13.11% decline from fiscal 2021.
| Period end | Operating Lease, Cost 3 month | Operating Lease, Cost 6 month | Operating Lease, Cost 9 month | Operating Lease, Cost 12 month |
|---|---|---|---|---|
| 2025-12-31 | $5.30M 10-K · filed 2026-03-10 | |||
| 2024-12-31 | $5.40M 10-K · filed 2026-03-10 | |||
| 2023-12-31 | $5.20M 10-K · filed 2025-03-11 | |||
| 2022-12-31 | $5.30M 10-K · filed 2024-03-12 | |||
| 2021-12-31 | $6.10M 10-K · filed 2023-03-16 | |||
| 2020-12-31 | $6.60M 10-K · filed 2022-03-08 | |||
| 2019-12-31 | $1.60M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-11 | $3.30M derived: sum of 2 quarters · filed 2020-03-11 | $5.00M derived: sum of 3 quarters · filed 2020-03-11 | $6.70M 10-K · filed 2020-03-11 |
| 2019-09-30 | $1.70M 10-Q · filed 2019-11-07 | $3.40M derived: sum of 2 quarters · filed 2019-11-07 | $5.10M 10-Q · filed 2019-11-07 | |
| 2019-06-30 | $1.70M 10-Q · filed 2019-08-09 | $3.40M 10-Q · filed 2019-08-09 | ||
| 2019-03-31 | $1.60M 10-Q · filed 2019-05-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Keros Therapeutics, Inc. (KROS) | United States | $0.229B | -2.55 |
| Cartesian Therapeutics, Inc. (RNAC) | United States | $0.231B | -2.04 |
| Whitehawk Therapeutics, Inc. (WHWK) | United States | $0.221B | |
| SIGA TECHNOLOGIES INC (SIGA) | United States | $0.234B | -93.33 |
| Eledon Pharmaceuticals, Inc. (ELDN) | United States | $0.219B | -3.23 |
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |
| Camp4 Therapeutics Corp (CAMP) | United States | $0.240B | -2.12 |
| Foghorn Therapeutics Inc. (FHTX) | United States | $0.213B | -4.43 |
| MACROGENICS INC (MGNX) | United States | $0.242B | -20.11 |
| Cue Biopharma, Inc. (CUE) | United States | $0.243B | -1.01 |